Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
25388501000001110 | Erythroped PI SF 125mg/5ml oral suspension (Abbott Laboratories Ltd) 140 ml (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
25388601000001114 | Erythroped PI SF 125mg/5ml oral suspension (Abbott Laboratories Ltd) 140 ml | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
40864001000001115 | Erythroped PI SF 125mg/5ml oral suspension (Amdipharm) 140 ml | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
54106201000001115 | Erythroped PI SF 125mg/5ml oral suspension (Amdipharm Plc) 140 ml | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
78838901000001112 | Erythroped PI SF 125mg/5ml oral suspension (AMCo) 140 ml | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
111533501000001118 | Erythroped PI SF 125mg/5ml oral suspension (Advanz Pharma) 140 ml | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets